We randomly assigned 11,140 patients with type 2 diabetes to undergo either standard glucose control or intensive glucose control, defined as the use of gliclazide (modified release) plus other drugs ...

A new study published in *The Lancet* last week noted that for people diagnosed with high blood pressure, intensive blood pressure control (defined as using medication and lifestyle changes to lower a ...

WINSTON-SALEM, N.C. – Jan. 21, 2025 – A new study from researchers at Wake Forest University School of Medicine shows that only 3½ years of intensive blood pressure control continues to significantly ...

Intensive glucose control doesn't reduce mortality risk in critically ill patients when compared with conventional glucose control. Instead, it increases the risk for severe hypoglycemia by threefold, ...

Please provide your email address to receive an email when new articles are posted on . In patients who had endovascular thrombectomy for acute ischemic stroke with large-vessel occlusion, intensive ...

Strategy reduced nephropathy risky by 21% in patients with type 2 diabetes, study finds. Intensive glucose control with gliclazide (modified release) and other agents reduced the risk of nephropathy ...

CHICAGO -- The cardiovascular outcome benefit of a tighter systolic blood pressure target was affirmed in patients with type 2 diabetes in the randomized BPROAD trial from China. A target of less than ...

Two studies provide additional support for lowering systolic blood pressure to an intensive goal of 120 mmHg – far below the standard guidelines of 140 mmHg – to reduce the risk of heart disease in ...

Please provide your email address to receive an email when new articles are posted on . Using intensive blood pressure control in patients with stages 4 to 5 chronic kidney disease may delay the onset ...

Heart conduction disorders can often lead to serious or fatal complications including complete heart block or heart failure. Left ventricular conduction disease occurs when there is an electrical ...